279 related articles for article (PubMed ID: 29413280)
1. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
Laird J; Ma J; Chau K; Chelius M; Shi W; Zhang Z; Lok BH; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):670-678. PubMed ID: 29413280
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy in the management of Langerhans cell histiocytosis.
Selch MT; Parker RG
Med Pediatr Oncol; 1990; 18(2):97-102. PubMed ID: 2304426
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis.
Kotecha R; Venkatramani R; Jubran RF; Arkader A; Olch AJ; Wong K
Am J Clin Oncol; 2014 Dec; 37(6):592-6. PubMed ID: 23466581
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.
Howarth DM; Gilchrist GS; Mullan BP; Wiseman GA; Edmonson JH; Schomberg PJ
Cancer; 1999 May; 85(10):2278-90. PubMed ID: 10326709
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
Modest MC; Garcia JJ; Arndt CS; Carlson ML
Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
[TBL] [Abstract][Full Text] [Related]
6. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease.
Kriz J; Eich HT; Bruns F; Heyd R; Schäfer U; Haverkamp U; Büntzel J; Seegenschmiedt H; Micke O
Radiat Oncol; 2013 Oct; 8():233. PubMed ID: 24103738
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis).
Gramatovici R; D'Angio GJ
Med Pediatr Oncol; 1988; 16(4):259-62. PubMed ID: 3262194
[TBL] [Abstract][Full Text] [Related]
9. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
[TBL] [Abstract][Full Text] [Related]
10. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
Kamath S; Arkader A; Jubran RF
J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
[TBL] [Abstract][Full Text] [Related]
13. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
14. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
15. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2012 Mar; 166(3):642-5. PubMed ID: 21967132
[TBL] [Abstract][Full Text] [Related]
16. [Langerhans cell histiocytosis in children: clinicopathological and ultrastructural analyses of 345 cases].
Yao XF; Wang X; Wang L; Fu LB; Zhang N; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):17-21. PubMed ID: 30641640
[No Abstract] [Full Text] [Related]
17. Langerhans cell histiocytosis treated with narrow-band ultraviolet B.
Aihara M; Hasegawa T; Okuyama Y; Hiruma M; Ikeda S
J Dermatol; 2011 Feb; 38(2):151-4. PubMed ID: 21269310
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcome in children with Langerhans cell histiocytosis.
Jubran RF; Marachelian A; Dorey F; Malogolowkin M
Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
[TBL] [Abstract][Full Text] [Related]
19. Does adjunctive chemotherapy reduce remission rates compared to cortisone alone in unifocal or multifocal histiocytosis of bone?
Baptista AM; Camargo AF; de Camargo OP; Odone Filho V; Cassone AE
Clin Orthop Relat Res; 2012 Mar; 470(3):663-9. PubMed ID: 22052526
[TBL] [Abstract][Full Text] [Related]
20. Fever and Skin Involvement at Diagnosis Predicting the Intractable Langerhans Cell Histiocytosis: 40 Case-Series in a Single Center.
Kobayashi T; Koga Y; Ishimura M; Nakashima K; Kato W; Ono H; Sonoda M; Eguchi K; Fukano R; Honjo S; Oda Y; Ohga S
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e148-e153. PubMed ID: 29293189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
